NCT07614126
- Conditions
- CTNNB1, L-DOPA
- Locations
-
- CHU de Montpellier Montpellier, Hérault, France
Clinical trial condition
L-DOPA
Explore clinical trials studying L-DOPA. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
L-DOPA trial results
NCT03754062
- Conditions
- Haloperidol, L-DOPA, Placebo
- Locations
-
- Centre for Neuroimaging Sciences London, United Kingdom